The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human study of an implantable microdevice for personalized drug testing in colorectal liver metastases.
 
Oliver Standring
No Relationships to Disclose
 
Joseph Grossman
Employment - Agenus
Stock and Other Ownership Interests - Agenus
 
Dhan Chand
Employment - Agenus
Leadership - Agenus
Stock and Other Ownership Interests - Agenus
Patents, Royalties, Other Intellectual Property - Dhan Chand reports provisional patents for the method of use of botensilimab
Travel, Accommodations, Expenses - Agenus
 
Nicholas Hornstein
No Relationships to Disclose
 
Craig Devoe
No Relationships to Disclose
 
Anna Levy
Honoraria - Intera Oncology
Research Funding - BeiGene (Inst); Merck (Inst)
 
Gerardo Vitiello
No Relationships to Disclose
 
Danielle Deperalta
No Relationships to Disclose
 
Matthew Weiss
No Relationships to Disclose
 
Husneara Rahman
Employment - Northwell Health
 
Arvind Rishi
No Relationships to Disclose
 
Igor Lobko
Travel, Accommodations, Expenses - Histosonics
 
David Tuveson
Stock and Other Ownership Interests - Cygnal Therapeutics; Dunad Therapeutics; Leap Therapeutics; Mestag Therapeutics; Xilis
Consulting or Advisory Role - Cygnal Therapeutics; Dunad Therapeutics; Leap Therapeutics; Mestag Therapeutics; Xilis
Research Funding - Mestag Therapeutics; Ono Pharmaceutical
Patents, Royalties, Other Intellectual Property - anti-CA199 for pancreatitis (pending); We have filed a provisional use patent for 5B1 to use to treat pancreatitis. with MabVax, which was acquired by BionTech.
 
Peter Westcott
Stock and Other Ownership Interests - RVMD, NGNE, RNTX, CABA, IDXX, EDIT, CRSP, NTLA
Honoraria - Pfizer Hellas
Travel, Accommodations, Expenses - Pfizer
 
Oliver Jonas
Employment - Brigham and Women's Hospital
Consulting or Advisory Role - Kibur Medical
Research Funding - Flare Therapeutics; Merck/Genentech; Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - implantable microdevices for testing of multiple drugs in tumors
 
Sepideh Gholami
Consulting or Advisory Role - Alphasights; Delcath Systems; Iota